Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ABOSABOS
Showing 8 of 20 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ACUMEN PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.1M shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $3M as of 2026-Q2. The position was increased (+174.3% shares). ABOS represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$3M

Current Shares

1.1M

Total Value Change

+$905,088

Total Shares Change

+277,330

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+174.3%
$3M0.0%$2.67
43
2026-Q1
Increased
416,238
+1.5%
$982,7550.0%$3.31
25
2025-Q4
Increased
410,206
+2.9%
$865,6860.0%$2.00
26
2025-Q3
Increased
398,778
+0.5%
$682,0390.0%$1.58
17
2025-Q2
Decreased
396,626
-54.0%
$460,1660.0%$1.12
0
2025-Q1
Decreased
861,899
-1.0%
$948,1820.0%$1.19
0
2024-Q4
Increased
870,555
+0.7%
$1.5M0.0%$1.75
26
2024-Q3
Increased
864,528
+6.5%
$2.1M0.0%$2.48
28

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used